Z-0095-2023 Class II Ongoing

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0095-2023 was initiated by Becton Dickinson & Company on Sep 15, 2022 and is designated Class II. Reason for recall: The affected product contains isobutylene which has recently demonstrated potential interference in determination of methanol by gas chromatography methods. The interference may lead to false positive… The recall status is ongoing. Affected quantity: 2,196,000.

Recall Details

Product Type
Devices
Report Date
Oct 26, 2022
Initiation Date
Sep 15, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,196,000

Product Description

BD Vacutainer Tube Sodium Fluoride: 100 mg, Potassium Oxalate: 20 mg, Catalog Number 367001. For collecting, transporting, separating, and processing blood for blood alcohol determination.

Reason for Recall

The affected product contains isobutylene which has recently demonstrated potential interference in determination of methanol by gas chromatography methods. The interference may lead to false positive results in methanol testing.

Distribution Pattern

Distribution US nationwide, Canada, New Zealand, and Hong Kong.

Code Information

UDI-DI: Case: 50382903670012; Shelf: 30382903670018; Each: 00382903670017; ALL LOTS are affected.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0095-2023
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.